Table 2. Clinical report of the patient.
Hb: hemoglobin; MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular volume; RBC: red blood cell; WBC: white blood cell; APTT: activated partial thromboplastin time; PT: prothrombin time; INR: international normalized ratio; FT3: free triiodothyronine; FT4: free thyroxine; TSH: thyroid-stimulating hormone; ALT: alanine aminotransferase; AST: aspartate aminotransferase; SGOT: serum glutamic-oxaloacetic transaminase; SGPT: serum glutamate pyruvate transaminase; HBsAg: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus; pg/mL: picograms per milliliter; ng/mL: nanograms per deciliter; μIU/mL: micro-international units per milliliter; mg/dL: milligrams per deciliter; U/L: units per liter; g/dL: grams per deciliter; fL: femtoliters
| Test | Patient's Value | Reference Value |
| Hb | 10.8 g/dL | 12-15 g/dL |
| MCHC | 32.2 g/dL | 32-36 g/dL |
| MCV | 71.3 fL | 80-100 fL |
| RBC count | 4.72 | 4.5-5.5x1012/L |
| WBC count | 10100 cells/μL | 4000-11000 cells/μL |
| Platelet count | 4.32x109/L | 150-450x109/L |
| APTT | 52.3 seconds | 30-40 seconds |
| PT | 13.5 seconds | 11-14 seconds |
| INR | 1.14 | 0.8-1.2 |
| Peripheral smear | Normocytic normochromic | N/A |
| FT3 | 3.94 pg/mL | 2.0-4.4 pg/mL |
| FT4 | 1.59 ng/dL | 0.93-1.7 ng/dL |
| TSH | 2.33 μIU/mL | 0.27-4.2 μIU/mL |
| Urea | 20 mg/dL | 10-50 mg/dL |
| Creatinine | 0.9 mg/dL | 0.6-1.2 mg/dL |
| ALT (SGPT) | 18 U/L | < 35 U/L |
| AST (SGOT) | 22 U/L | < 35 U/L |
| Total bilirubin | 0.5 mg/dL | 0.1-1.2 mg/dL |
| Random blood sugar | 123 mg/dL | < 140 mg/dL |
| HBsAg | Negative | N/A |
| HCV | Negative | N/A |
| HIV | Negative | N/A |